Prevention of Rare Diseases and Orphan Drug Act Article 24
Applicants for registration and market approval, clinical trials, issuance or extension of a permit, or ad hoc applications under this Act shall pay for the review, registration, or licensing; the central competent authority shall stipulate the fee schedules.
中文原文 罕見疾病防治及藥物法第24條
依本法申請查驗登記、臨床試驗、許可證之核發、展延或專案申請者，應繳納審查費、登記費或證照費；其費額，由中央主管機關定之。